Acute & Interventional Cardiology 2003; Volume 10: pages AIC 1- AIC 88
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 63–AIC 65
The ability to deliver increased cardiac services in line with the National Service Framework (NSF) is dependent on a skilled workforce being developed at an...
Read More
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 66–AIC 70
Thrombolytic therapy remains the predominant reperfusion strategy for ST segment elevation myocardial infarction (STEMI) in the UK, with government policy directed towards optimising thrombolytic delivery....
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 75–AIC 77
Recent developments in the management of non-ST elevation acute coronary syndromes (ACS) have included the introduction of glycoprotein (GP) IIb/IIIa inhibitors. The National Institute for...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 78–AIC 81
End-stage heart failure represents a major public health challenge and carries a poor prognosis. After a 30-year gestation period, mechanical assist devices are now poised...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 82–AIC 88
Background: With an incidence rate of 30–50%, atrial fibrillation (AF) after bypass surgery continues to be one of the most common complications. The possibilities of...
Read More
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 37–AIC 40
The Coronary Artery Revascularisation in Diabetes (CARDia) trial is an investigator-initiated study and is the first prospective study designed specifically to address the hypothesis that...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 45–AIC 48
The objective of this survey was to estimate the proportion of episodes of acute coronary syndromes (ACS) without ST segment elevation in relation to the...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 49–AIC 51
There is a lack of standards pertaining to stopping antiplatelet agents in patients with acute coronary syndromes prior to coronary surgery. We conducted a national...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 52–AIC 55
Cardiopulmonary bypass and the median sternotomy incision have revolutionised cardiac surgery, helping coronary artery bypass to become a routine procedure. Cardiopulmonary bypass was originally developed...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 56–AIC 58
Early angiography and revascularisation are beneficial for patients with non-ST segment elevation myocardial infarction (NSTEMI). However, the Prospective Registry of Acute Ischaemic Syndromes in the...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 59–AIC 60
Infective endocarditis can be difficult to diagnose, especially in the absence of typical clinical features or Duke criteria. Seeding of emboli to the cerebral cortex...
Read More
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 3–AIC 5
The donor crisis in heart transplantation John Pepper n the area of heart failure, public debate and research funding have been focused on new trends...
Read More
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 6–AIC 7
With the publication recently of the results of learned deliberations of two working parties of the Royal College of Physicians (RCP),1,2 attention continues to focus...
Read More
EDITORIAL
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 9–AIC 11
The first public report on how the NHS manages acute
myocardial infarction (MI) in English hospitals was published on
19th November 2002.1 The report, based...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 17–AIC 20
Glucose-insulin-potassium (GIK) therapy addresses the metabolic changes of ischaemia secondary to acute myocardial infarction. These changes include elevated plasma free fatty acid concentration and glucose...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 22–AIC 27
A significant left main coronary artery (LMCA) stenosis is an important predictor of survival in patients with coronary artery disease. In the past, percutaneous coronary...
Read More
CLINICAL ARTICLE
Br J Cardiol (Acute Interv Cardiol) 2003;10(1):AIC 28–AIC 32
The objective of this study was to describe the context, procedural outcome and long-term results of contemporary small vessel (SV) coronary artery stenting. It was...
Read More